Vir Biotechnology (VIR) Return on Capital Employed [ROCE] (2019 - 2026)
Vir Biotechnology's Return on Capital Employed [ROCE] was -19.53% in Q3 2026, up 33.69 percentage points from -53.22% a year earlier and up 7.80 percentage points from the prior quarter.
Powered by 
Analysis
Vir Biotechnology (VIR) Return on Capital Employed [ROCE] (2019 - 2026) Analysis & Trends
For FY2025, Return on Capital Employed [ROCE] at Vir Biotechnology came in at -43.26%, down 5.11 percentage points from FY2024.
- Return on Capital Employed [ROCE] has now declined for three consecutive years, though with a five-year change of +4.92 percentage points (FY2020 to FY2025).
- In earlier years, Return on Capital Employed [ROCE] was -38.15% in FY2024 (-6.83 pp), -31.32% in FY2023 (-75.93 pp), 44.62% in FY2022 (+6.20 pp) and 38.42% in FY2021 (+86.60 pp).
- The Q3 2026 figure marks the highest quarterly Return on Capital Employed [ROCE] since Q2 2023.
- Compared with a year earlier, Return on Capital Employed [ROCE] has increased for three straight quarters, with an average year-over-year change of -0.01 percentage points over the last eight quarters.
- The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was Q1 2022 (a gain of 150.32 percentage points); the worst was Q1 2023 (a drop of 107.13 percentage points).
- Per Business Quant data, VIR's Return on Capital Employed [ROCE] in the three quarters before Q3 2026 was -27.33% (Q2 2026), -50.19% (Q1 2026) and -52.20% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 35.41% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 17.52% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 21.60% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 4.65% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.91% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 17.37% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -6.15% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 11.32% |
| 10 | Vir Biotechnology | 2.23 Bn | 313.19 Mn | 188,000.00 | -19.53% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -19.53% |
| Jun 30, 2026 | -27.33% |
| Mar 31, 2026 | -50.19% |
| Dec 31, 2025 | -52.20% |
| Sep 30, 2025 | -53.22% |
| Jun 30, 2025 | -52.96% |
| Mar 31, 2025 | -53.18% |
| Dec 31, 2024 | -44.18% |
| Sep 30, 2024 | -41.52% |
| Jun 30, 2024 | -34.52% |
| Mar 31, 2024 | -35.24% |
| Dec 31, 2023 | -37.88% |
| Sep 30, 2023 | -35.15% |
| Jun 30, 2023 | -14.09% |
| Mar 31, 2023 | -14.41% |
| Dec 31, 2022 | 37.22% |
| Sep 30, 2022 | 66.20% |
| Jun 30, 2022 | 57.44% |
| Mar 31, 2022 | 92.72% |
| Dec 31, 2021 | 33.90% |
API Access
Vir Biotechnology Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=VIR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "VIR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=VIR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();